Business Wire

WIKIFARMER

9.2.2023 08:34:50 CET | Business Wire | Press release

Share
Wikifarmer Democratizes Agricultural Commerce. Put Simply, It Enables Farmers to Sell Directly to Businesses at Higher Margins and Educates Them on Modern Farming Techniques

Wikifarmer, the direct farmer-to-business agricultural marketplace—aptly described as the “Wikipedia of farming”—has raised a €5M in a late seed round, led by Point Nine.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230208005806/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Ilias Sousis and Petros Sagkos, founders of Wikifarmer (Photo: Business Wire)

The Athens-based startup will use the funding for pan-European expansion and to enrich its knowledge library. It will further enhance its platform to fully digitize transactions end-to-end, and offer innovative financial and logistic solutions to both buyers and sellers.

As a whole, Wikifarmer is an ecosystem that supports farmers from start to finish. It enables them to learn, sell and make their business lives easier.

On the supply side, farmers receive the value they deserve: they produce more efficiently, sell directly, and enjoy an increase in their profitability by up to 300%. Higher profitability for farmers means a higher capacity for investments in production, higher employment, and higher sustainability.

On the demand side, Wikifarmer acts as a purchasing assistant for B2B buyers, such as wholesalers, larger hotels, restaurant chains, small and medium size retailers, or food processing units. It provides hassle-free sourcing of agricultural products, helps parties to negotiate prices efficiently online, offers logistics support, ensures security and transaction transparency and facilitates 60 - 90 days of credit.

What’s next?

“Our vision is to restructure the supply chain, digitize processes, and ultimately generate more value for all parties involved. Our mission is to become Europe’s leading B2B trading platform within the next two years. This round of funding will allow us to accelerate our product development in order to offer 360° coverage of agricultural transactions” explains Wikifarmer’s Co-Founder and CEO, Ilias Sousis.

Petros Sagos, Co-Founder and Chief Science Officer, concludes: “Above all, we hope this funding will enable us to turn our long-standing vision into reality: democratize agriculture and support farmers in modernizing their techniques, selling their products, and earning the value they deserve"

Point 9 is a B2B SaaS and B2B marketplace-specialized VC firm with investments such as Revolut, Delivery Hero, Docplanner, and cargo.one and one of the highest “seed-to-winner” rates in the industry. The round was complemented by relevant Business Angels (the founders of cargo.one, Nikos Moraitakis - co-founder and CEO of Workable, Przemyslaw Budkowski - CEO of Merxu, Cihan Aksakal - founder of Zenjob, Louis Pfizner - founder of Caya.com and Treatwell), as well as prior investors including leading Greek VC Metavallon, plus angels such as Sophia Bendz.

“B2B marketplaces, which bring mostly analog industries online, are a core area of focus for us at Point Nine. We have been partnering with one or two new B2B marketplaces every year, for the last 7 years, including REKKI (restaurants) in 2016, Container xChange (containers) and Laserhub (metal parts) in 2017, cargo.one (air cargo) in 2018, MerXu (industrial products) in 2019, Rooser (seafood) in 2020, and now Wikifarmer. The food industry is gigantic and presents its own challenges, but we’ve been impressed by Ilias’s and Peter’s unique approach to digitizing the industry. We’re excited to play a small role in their long-term success” says Louis Coppey, partner at Point Nine.

The Industry and Context

In addition to being the no.1 employer[1] in the world, the agrifood industry generates a total turnover of 1.2 trillion Euros in Europe alone[2] and has a major impact on the everyday life of every single person on the planet. Yet, a significant number of farmers still lack access to modern agricultural best practices, and it remains one of the least digitized sectors. The pandemic, the outbreak of the war in Ukraine, along with climate change, population growth predictions, and the scarcity of natural resources have all had a major impact on the supply chain, and eventually, the food on our plates. The past few years have been challenging for the agrifood sector, placing increased demands on food security and sustainable solutions. Wikifarmer responds to the need for new technologies and ideas that have the potential to reshape agriculture, and this is reflected in the startup’s growth.

The Product

Wikifarmer is an ecosystem of content and agricultural products that promote a fairer, more transparent and sustainable value chain in the food industry. With Wikifarmer, farmers can sell their output to multiple buyers, achieve a better price, monitor fair market prices, and access international markets. The startup also offers instant payments to farmers and helps them with logistics and financing, allowing them to increase their profitability on the Wikifarmer marketplace. At the same time, it provides them with a wide collection of agricultural best practices and how-to guides, which have been translated into 16 languages and are freely accessible on the Wikifarmer Library.

On the platform, farmers can use the Wikifarmer library to upgrade their techniques, in order to improve the quality of their produce and boost their efficiency. Then, they can upload their products on the Wikifarmer Market and sell directly to buyers from all over the world.

The story behind the startup

Looking back to where everything started, the founding team is a metaphor for Wikifarmer's mission: matching digitization with agricultural science. CEO Ilias Sousis, a senior ex-Googler for 11 years, and Chief Science Officer Petros Sagos, an accomplished agronomist, have been best friends since primary school. "We started Wikifarmer because we thought things should be done differently" they explain.

Today, Wikifarmer is approaching 1m unique visitors per month. It has allowed thousands of businesses to slash costs by up to 30%, enabling farmers to sell their products without intermediaries, while growing their potential clientele, reducing waste, and tripling their profitability. The Wikifarmer library has been dubbed the “Wikipedia of Farming” by the United Nations and is now available in 16 languages.

About Wikifarmer

Wikifarmer is a global platform whose mission is to empower farmers by offering them education as well as direct access to commercial markets, so they can sell their products at fair prices.

About Point Nine

Founded in 2011, Point Nine is a European early-stage venture capital firm focused on B2B SaaS and B2B marketplace start-ups in Europe and North America. The firm is a seed investor in more than 150 companies in over 30 countries, including Algolia, Brainly, Chainalysis, Clio, Contentful, Delivery Hero, DocPlanner, Front, Loom, Mambu, Revolut, and Typeform, amongst others. Point Nine has one of the highest “seed-to-winner” rates in the industry.

About Metavallon

Metavallon VC specializes in pre-seed and seed-stage funding of disruptive technology companies. The firm invests in and works alongside ambitious entrepreneurs, helping them build transformational businesses across multiple stages, geographies and industries. Metavallon VC’s mission is to engage at a very early stage and invest in companies that will operate at the forefront of business and technology innovation.

[1] United Nations, 2017
[2] https://www.opendei.eu/agri-food-sector/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230208005806/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Merz Therapeutics Announces Completion of Recruitment in Two Phase III Trials Investigating XEOMIN® (incobotulinumtoxinA) for Migraine Prevention15.10.2026 08:00:00 CEST | Press release

Patient recruitment completed six months ahead of schedule in two global Phase III trials for migraine prevention MINT-E and MINT-C are evaluating XEOMIN® (incobotulinumtoxinA) for the preventive treatment of episodic and chronic migraine Trials recruited approximately 1,800 adults across 109 study sites in North America and Europe Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced the completion of patient recruitment in two global Phase III clinical trials, MINT-E (NCT07018700) and MINT-C (NCT07018713), evaluating the efficacy and safety of XEOMIN® (incobotulinumtoxinA) for the prevention of episodic and chronic migraine in adults. The trials recruited approximately 1800 adults across 109 study sites in North America and Europe. Migraine affects around 1.1 billion people worldwide, posing a significant burden on patients, society and healthcare systems.1 Both trials are evaluating the change in monthly migraine days from baseline to Month

Tourism Malaysia and Alipay+ Partner to Accelerate Malaysia’s Digital Tourism Transformation15.10.2026 07:10:00 CEST | Press release

Collaboration will connect seamless payments, in-app digital engagement and AI-powered travel services to enhance the visitor journey, empower businesses of all sizes and unlock wider cross-border commerce opportunities Tourism Malaysia and Alipay+, the unified wallet gateway of Ant International, today signed a Memorandum of Understanding (MoU) to accelerate cross-border commerce and digitalise merchant engagement across Malaysia's tourism economy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014035900/en/ (From left) Mr Mohd Akbal Setia (Head of VM2026 Secretariat and Senior Director, Advertising & Digital Tourism); Mr Mohd Amirul Rizal Abdul Rahim (Director General, Tourism Malaysia); Mr Danny Chung (General Manager of Alipay+ Global Growth Center and Vice President of Ant International); Mr Michael Guo, Alipay+ General Manager of SEA, South Asia and ANZ, Ant International) As Malaysia welcomes visitors for Visit Mal

PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis15.10.2026 07:00:00 CEST | Press release

Patient-reported outcomes from a phase II study of nemolizumab in children aged 2 to 11 with moderate-to-severe atopic dermatitis show meaningful reductions in itch severity, better sleep and improved quality of life, maintained for a year1 Currently, there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis, despite the high unmet need – the disease can significantly reduce quality of life for children and create burden on their families2-8 These findings expand on the clinical evidence base for nemolizumab, which has multiple global approvals for adult and pediatric patients 12 years of age and older with moderate-to-severe atopic dermatitis, and adults with prurigo nodularis9,10 Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new phase II data showing that nemolizumab provided meaningful improvements in itch, sleep disturbance, and quality of life in children aged 2 to 11 years with moderate-to-severe

Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 115.10.2026 02:30:00 CEST | Press release

− ORZEYFUL is now available in Japan and China following approvals within a month of each other by China’s National Medical Products Administration (NMPA), the U.S. Food and Drug Administration (FDA) and Japan’s Ministry of Health, Labour and Welfare (MHLW) − Discovered by Takeda scientists in Japan, ORZEYFUL is the lead medicine in Takeda’s orexin franchise, with multiple programs for sleep-wake disorders and conditions where orexin biology plays a role − ORZEYFUL set to launch next month in the U.S., following completion of DEA scheduling; Health Authority submissions underway worldwide Takeda (TSE:4502/NYSE:TAK)announced today that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (NT1), providing first access to clinicians to prescribe treatment with the new class of medicine. ORZEYFUL is a first-in-class orexin receptor 2 (OX2R) agonist, in tablet form, designed to treat the underlying orexin deficiency associated with NT1. “We’re ex

Celltrion to Spotlight Subcutaneous (SC) Infliximab (Remsima™ SC) and Broader IBD Portfolio at UEG Week 202615.10.2026 02:10:00 CEST | Press release

Celltrion to showcase its broad IBD portfolio, including Remsima™ IV, Remsima™ SC, the newly launched Remsima™ IV Liquid formulation, Steqeyma™ and Yuflyma™Symposium and Meet the Experts sessions to highlight long-term clinical evidence and real-world experience with subcutaneous (SC) infliximab (Remsima™ SC) across different IBD patient scenarios Celltrion, Inc. (KRX:068270) announced its participation in United European Gastroenterology (UEG) Week 2026, in Barcelona, Spain (Oct. 17-20), highlighting its inflammatory bowel disease (IBD) treatment portfolio, led by Remsima™ SC (subcutaneous infliximab). Celltrion will showcase its comprehensive infliximab portfolio, comprising Remsima™ intravenous (IV) and subcutaneous (SC) formulations, as well as the Remsima™ IV liquid formulation launched in Europe earlier this year.1 Additionally, the company will highlight its broader IBD portfolio, including SteQeyma™ (ustekinumab) and Yuflyma™ (adalimumab), reflecting its continued efforts to ex

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye